2013
DOI: 10.3109/10717544.2013.834420
|View full text |Cite
|
Sign up to set email alerts
|

Long-circulating nanoliposomes (LCNs) sustained delivery of baicalein (BAI) with desired oral bioavailabilityin vivo

Abstract: Long-circulating nanoliposomes (LCNs) containing Baicalein (BAI) were prepared by diethyl ether injection method in this paper. Using soybean phosphatidylcholine (SPC) and cholesterol (CHOL) as the carrier ingredients, BAI-loaded LCNs were formulated in optimized condition with encapsulation efficiency (EE) of 41.5 AE 4.77%. The average diameter of BAI-loaded LCNs was $709 nm determined by dynamic light scattering (PDI 0.43). Drug storage stability study showed that BAI-loaded LCNs were highly stable in phosph… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
17
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(18 citation statements)
references
References 24 publications
1
17
0
Order By: Relevance
“…Gaur et al (2014) reported that a solid lipid nanoparticle formulation of efavirenz showed mean particle size of 124 AE 3.2 nm and exhibited 10.98-fold increase in area under the concentration-time curve (AUC) in comparison to efavirenz suspension. The plasma level of baicalein, when administering its long-circulating nanoliposomes with an approximately 700 nm particle size, was significantly improved, and the relative bioavailability of baicalein was 452% in mice (Liang et al, 2013). Similarly, the aqueous solubility of kaempferol was increased approximately 139-fold when it was developed into a nanoparticle system, which resulted in a significant improvement in antioxidant activity (p < 0.05) compared with the pure drug (Tzeng et al, 2011).…”
Section: Introductionmentioning
confidence: 93%
“…Gaur et al (2014) reported that a solid lipid nanoparticle formulation of efavirenz showed mean particle size of 124 AE 3.2 nm and exhibited 10.98-fold increase in area under the concentration-time curve (AUC) in comparison to efavirenz suspension. The plasma level of baicalein, when administering its long-circulating nanoliposomes with an approximately 700 nm particle size, was significantly improved, and the relative bioavailability of baicalein was 452% in mice (Liang et al, 2013). Similarly, the aqueous solubility of kaempferol was increased approximately 139-fold when it was developed into a nanoparticle system, which resulted in a significant improvement in antioxidant activity (p < 0.05) compared with the pure drug (Tzeng et al, 2011).…”
Section: Introductionmentioning
confidence: 93%
“…Its Cmax was much higher and half-life was much longer than free baicalein (Ts a i et al 2012; Zhang et al 2011a). Complexation with delivery systems could enhance the solubility and dissolution of baicalein (Huang et al 2014; Liang et al 2013; Liu et al. 2006; Liu et al 2012; Zhang et al 2014a).…”
Section: Bioavailability and Improvementmentioning
confidence: 99%
“…The results of DLS analysis were presented in Figure 2. method [14]. The PDI was determined to examine the level of uniformity of particle size.…”
Section: The Size Pdi and Zeta Potential Of Lp And Bai-lpmentioning
confidence: 99%
“…BAI, a major constituent of Scutellaria baicalensis Georgi, has a variety of pharmacological effects such as antivirus, antibacterial, and anticancer [13]. According to previous studies, BAI is a very promising and attractive drug in treatment of bladder cancer [14]. Our research group has conducted years of researches on anticancer effects and mechanisms of BAI.…”
Section: Introductionmentioning
confidence: 99%